Recruiting
Peripheral venous disease
RecruitingInvestigationalNo placebo
Study to evaluate the efficacy and safety of personalized tissue engineered veins in patients with severe chronic venous insufficiency
InvestigationalNo placebo
- Disease:Peripheral venous disease
- Substances:ALLOGENEIC VEIN TISSUE SEGMENT, DECELLULARISED, WITH A FUNCTIONAL VALVE PERFUSED WITH AUTOLOGOUS PERIPHERAL BLOOD
Countries:
Spain
Spain- Participants:18–64 years · 65+ years
- Substances:ALLOGENEIC VEIN TISSUE SEGMENT, DECELLULARISED, WITH A FUNCTIONAL VALVE PERFUSED WITH AUTOLOGOUS PERIPHERAL BLOOD
- Sponsor:VeriGraft AB